RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 107 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $177,377 | +143.6% | 164,238 | +190.9% | 0.03% | +130.8% |
| Q2 2023 | $72,827 | -82.6% | 56,455 | -82.2% | 0.01% | -85.2% |
| Q1 2023 | $418,163 | +1233.5% | 316,790 | +1415.3% | 0.09% | +1157.1% |
| Q4 2022 | $31,359 | -94.0% | 20,906 | -95.3% | 0.01% | -94.6% |
| Q3 2022 | $525,000 | +226.1% | 444,719 | +212.8% | 0.13% | +97.0% |
| Q2 2022 | $161,000 | +436.7% | 142,187 | +1294.5% | 0.07% | +407.7% |
| Q1 2022 | $30,000 | -73.9% | 10,196 | -76.4% | 0.01% | -80.0% |
| Q4 2021 | $115,000 | -28.1% | 43,256 | +17.3% | 0.06% | +20.4% |
| Q2 2021 | $160,000 | – | 36,878 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 9,105,691 | $30,140,000 | 5.99% |
| Sio Capital Management, LLC | 1,888,181 | $6,250,000 | 3.50% |
| DAFNA Capital Management LLC | 473,478 | $1,567,000 | 1.32% |
| Cormorant Asset Management, LP | 2,000,000 | $6,620,000 | 0.96% |
| Ghost Tree Capital, LLC | 1,100,000 | $3,641,000 | 0.68% |
| Rhenman & Partners Asset Management AB | 1,282,000 | $4,243,000 | 0.67% |
| Palo Alto Investors LP | 4,254,623 | $14,083,000 | 0.67% |
| NEA Management Company, LLC | 3,243,150 | $10,375,000 | 0.36% |
| Telemetry Investments, L.L.C. | 170,000 | $563,000 | 0.25% |
| NJ State Employees Deferred Compensation Plan | 355,000 | $1,175,000 | 0.22% |